News

As at September 2024, Passage Bio had cash of US$85m and no debt. Importantly, its cash burn was US$59m over the trailing twelve months. Therefore, from September 2024 it had roughly 17 months of ...
Passage Bio, Inc., a biotechnology firm specializing in biological products, has transferred its stock listing from The Nasdaq Global Select Market to The Nasdaq Capital Market. The transition ...
A high-level overview of Passage Bio, Inc. (PASG) stock. View ... IPO Update: Passage Bio Finalizes $126 Million IPO Plan ... Is Passage Bio, Inc. listed on the NASDAQ or NYSE?
On September 19, 2024, Orbimed Advisors LLC, a prominent investment firm, executed a significant transaction involving the shares of Passage Bio Inc (NASDAQ:PASG). Despite this reduction, Orbimed ...
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although software-as-a-service business Salesforce.com lost money for years while it grew recurring ...
Passage Bio, Inc. (PASG) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is ...
Wedbush assumed coverage of Passage Bio (PASG) with an Outperform rating and price target of $4, up from $3. Market sentiment may be different from the days when an extensive gene therapy pipeline ...
PHILADELPHIA, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (NASDAQ: PASG), a clinical stage genetic medicines company focused on improving the lives of patients with neurodegenerative ...
(RTTNews) - Passage Bio (PASG), a clinical-stage genetic medicines company, on Friday announced positive interim data from its ongoing Phase 1/2 upliFT-D clinical trial evaluating PBFT02 for the ...
Just because a business does not make any money, does not mean that the stock will go down. For example, although software-as-a-service business Salesforce.com lost money for years while it grew ...
In March 2024, Passage Bio had US$105m in cash, and was debt-free. Looking at the last year, the company burnt through US$75m. That means it had a cash runway of around 17 months as of March 2024.